Jennifer A. Fox - 12 Jul 2023 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
Director
Signature
/s/ Todd Girolamo, attorney in fact
Issuer symbol
PROK
Transactions as of
12 Jul 2023
Net transactions value
$0
Form type
4
Filing time
13 Jul 2023, 16:17:24 UTC
Previous filing
02 Mar 2023
Next filing
17 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PROK Director stock option (right to buy) Award $0 +46,632 $0.000000 46,632 12 Jul 2023 Class A Ordinary Shares 46,632 $10.92 Direct F1
transaction PROK Director stock option (right to buy) Award $0 +42,515 $0.000000 42,515 12 Jul 2023 Class A Ordinary Shares 42,515 $10.92 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting subject to Ms. Fox's continued service with the Company through the applicable vesting date.
F2 The option shall vest and become exercisable in two equal annual installments on July 11, 2024 and July 11, 2025 subject to Ms. Fox's continued service with the Company through the applicable vesting date.